OUR NAME IS OUR MISSION: To improve and ACCELERATE the development of new treatments for children and adolescents with cancer.
ACCELERATE is now a registered non-profit organisation based in Brussels. Two new people have joined the organisation: Teresa de Rojas (Spain), MD, PhD, a young paediatric oncologist from Spain working as Scientific Coordinator, and Michael Vranken (Belgium) MPharm, as Communication & Policy Administrator. We are delighted to welcome them and support the growing activities of ACCELERATE.
Furthermore, the first issue of ACCELERATE’s newsletter was launched in October. The newsletter aims to give an overview of all the activities, updates on working groups, perspectives from various members of the community, etc. You may find here the first issue of the newsletter here.
Last but not least, we invite you follow us on Twitter: @ACCELERATEcure and engage in the discussions.
The 9th ACCELERATE Paediatric Oncology Conference will take place virtually on 4-5 February 2021.
The time of the conference has been chosen to best accommodate various time zones, so the event will start at 3pm CET on both dates.
Don’t miss this exceptional opportunity to meet, discuss and network with all stakeholders committed to improving the development of new life-saving medicines for children and adolescents with cancer!
We look forward to meeting you virtually on 4-5 February to drive forward the development of innovative medicines for children and adolescents with cancer!
6th Paediatric Strategy Forum for Medicinal Product Development of CAR T-cells in Children and Adolescents
The Forum is re-scheduled and will now take place virtually on 25-26-27 May 2021.
The 6th Multi-stakeholder Paediatric Strategy Forum, organised by ACCELERATE in collaboration with the European Medicines Agency (EMA) and with the participation of the U.S. Food and Drug Administration (FDA), will focus on CAR T-cells in children and adolescents.
More details are available on the ACCELERATE website.
We are delighted that the following important papers were published in August and September 2020:
European Journal of Cancer: 'Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration', September 2020
European Journal of Cancer: ‘Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration’, September 2020
The Lancet Child & Adolescent Health: 'The RACE to accelerate drug development for children with cancer' (18 August 2020)
You may find all the publications here.
More information: www.accelerate-platform.org